United States of America (the)

In-vitro diagnostic substance manufacturing

United Arab Emirates (the)

Afghanistan

Antigua and Barbuda

Albania

Angola

Argentina

Austria

Australia

Barbados

Bangladesh

Belgium

Burkina Faso

Bulgaria

Bahrain

Burundi

Benin

Bolivia, Plurinational State of

Brazil

Bahamas

Bhutan

Belize

Canada

Central African Republic

Congo

Switzerland

Côte d'Ivoire

Chile

Cameroon

China

Colombia

Costa Rica

Cyprus

Czechia

Germany

Denmark

Dominica

Dominican Republic

Algeria

Ecuador

Estonia

Egypt

Spain

Ethiopia

Finland

Fiji

France

Gabon

United Kingdom

Grenada

Gambia

Guinea

Equatorial Guinea

Greece

Guatemala

Guinea-Bissau

Hong Kong

Honduras

Croatia

Haiti

Hungary

Indonesia

Ireland

Israel

India

Iraq

Iran, Islamic Republic of

Iceland

Italy

Jamaica

Jordan

Japan

Kenya

Cambodia

Kiribati

Saint Kitts and Nevis

Korea, Republic of

Kuwait

Kazakhstan

Lao People's Democratic Republic

Lebanon

Saint Lucia

Sri Lanka

Lesotho

Lithuania

Luxembourg

Latvia

Morocco

Moldova, Republic of

North Macedonia

Mali

Myanmar

Mongolia

Malta

Mauritius

Maldives

Malawi

Mexico

Malaysia

Namibia

Niger

Dental laboratories

Home health care services

Nursing and community care facilities

Emission intensity of supply chain (with margins i.e. cradle to shelf) in US dollars spend on: in-vitro diagnostic substance manufacturing. This factor is representative of the described goods or services category as defined by the 2017 version of the North American Industry Classification System (NAICS). Refer to the source for the source-specific data quality assessment. Retrieved from Supply Chain Factors Dataset v1.3.

Emission intensity of supply chain (with margins i.e. cradle to shelf) in US dollars spend on: in-vitro diagnostic substance manufacturing. This factor is representative of the described goods or services category as defined by the 2017 version of the North American Industry Classification System (NAICS). Refer to the source for the source-specific data quality assessment. Retrieved from Supply Chain Factors Dataset v1.2.

Property	Value
Name	In-vitro diagnostic substance manufacturing
Sector	Health and Social Care
Category	Health Care
Source	EPA
Region	United States of America (the) (US)
Unit Type	Money
Year	2019 2022
LCA Activity	cradle_to_shelf

Emission Factor Name	Region	Source	Year	Unit
In-vitro diagnostic substance manufacturing	United States of America (the)	EPA	2022	Money
In-vitro diagnostic substance manufacturing	United States of America (the)	EPA	2019	Money

In-vitro diagnostic substance manufacturing

Activity summary

API Reference

Interested in licensing this data?

Related factors

Health Care Emission Factors

Dental laboratories

Home health care services

Nursing and community care facilities